Skip to main content

Table 3 Distribution of oral mucosal diseases with HCV-related liver diseases

From: Analysis of the factors motivating HCV-infected patients to accept interferon therapy

No Sex Age Liver disease Oral lichen planus Oral cancer Oral leukoplakia Aphthous stomatitis Xerostomia Oral candidosis Traumatic ulcer Benign tumor
(n = 11) (n = 1) (n = 1) (n = 3) (n = 3) (n = 2) (n = 1) (n = 3)
buccal mucosa gingiva tongue lower lip oral floor soft palate type onset tongue tongue     tongue  
1 F 55 CH-C       erosive during IFN therapy        
2 F 58 CH-C                
3 M 54 CH-C    erosive before IFN therapy        
4 M 62 CH-C      reticular during IFN therapy        
5 F 66 CH-C       erosive before IFN therapy        
6 M 61 CH-C               
7 F 55 CH-C       reticular during IFN therapy        
8 F 62 CH-C             (with fissured tongue)    
9 F 72 CH-C       erosive before IFN therapy        
10 F 70 CH-C             (with fissured tongue)    
11 M 58 CH-C               
12 F 57 CH-C       erosive before IFN therapy (post ope.)       
13 F 60 CH-C                
14 F 71 LC-C       erosive before IFN therapy        
15 F 66 CH-C                
16 M 67 CH-C                
17 F 66 CH-C                
18 F 64 CH-C       erosive before IFN therapy        
19 F 61 CH-C       reticular before IFN therapy        
20 F 29 CH-C                
21 F 67 CH-C       reticular before IFN therapy        
22 F 49 CH-C                
23 M 48 CH-C               
  1. CH-C: chronic hepatitis C, LC-C: HCV-related liver cirrhosis, IFN: interferon therapy, ope: operation.
  2. The circles indicate the presence of the disease.